{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:13:22Z","timestamp":1774908802560,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81904179"],"award-info":[{"award-number":["81904179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Hepatic fibrosis (HF) is the common pathological basis of chronic liver disease (CLD). Many data indicate that serum vitamin D (VD) levels in patients with liver fibrosis are significantly lower than those without liver fibrosis, and lower level of serum 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub> is also an independent risk factor for patients with liver fibrosis combined with other diseases. VD has the functions of anti-fibrosis, regulating cell proliferation and differentiation, anti-inflammatory, and immune regulation, Therefore, serum 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub> level may be negatively correlated with the progression of liver fibrosis. But there is absent convincing evidence-based medicine to confirm the efficacy of VD supplementation for CLD. Thus, we aimed to conduct this meta-analysis to summarize the efficacy of VD supplementation on the progression of fibrosis in patients with CLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The study only selects clinical randomized controlled trials of VD supplementation for CLD. We will search each database from the built-in until September 2020. The English literature mainly searches Cochrane Library, Pubmed, EMBASE, and Web of Science. While the Chinese literature comes from CNKI, CBM, VIP, and Wangfang database. Meanwhile, we will retrieve clinical trial registries and gray literature. Two researchers worked independently on literature selection, data extraction and quality assessment. The dichotomous data is represented by relative risk (RR), and the continuous is expressed by mean difference (MD) or standard mean difference (SMD), eventually the data is synthesized using a fixed effect model (FEM) or a random effect model (REM) depending on the heterogeneity. The serum VD level, hepatic function and serological indexes of hepatic fibrosis were evaluated as the main outcomes. While several secondary outcomes were also evaluated in this study. The statistical analysis of this Meta-analysis was conducted by RevMan software version 5.3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This meta-analysis will further determine the beneficial efficacy of VD supplementation on the progression of fibrosis in patients with CLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study determines the positive efficacy of VD supplementation for CLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>This review is based solely on a secondary study of published literatures and does not require ethics committee approval. Its conclusion will be disseminated in conference papers, magazines or peer-reviewed journals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration number:<\/jats:title>\n            <jats:p>INPLASY202040054.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020296","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:34:00Z","timestamp":1588970040000},"page":"e20296","source":"Crossref","is-referenced-by-count":8,"title":["The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease"],"prefix":"10.1097","volume":"99","author":[{"given":"Tiantian","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Zuo","sequence":"additional","affiliation":[{"name":"School of basic medical sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengju","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penglong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of basic medical sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Wei","sequence":"additional","affiliation":[{"name":"School of basic medical sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"School of basic medical sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-9006","authenticated-orcid":false,"given":"Yongxiang","family":"Gao","sequence":"additional","affiliation":[{"name":"College of International Education of Chengdu University of Traditional Chinese Medicine, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueping","family":"Li","sequence":"additional","affiliation":[{"name":"School of basic medical sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20240308","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Aydin","year":"2018","journal-title":"Turk J Gastroenterol"},{"key":"R2-20240308","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00508-016-1127-1","article-title":"Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis","volume":"129","author":"Paternostro","year":"2017","journal-title":"Wien Klin Wochenschr"},{"key":"R3-20240308","first-page":"297","article-title":"Vitamin D deficiency in patients with liver cirrhosis","volume":"29","author":"Konstantakis","year":"2016","journal-title":"Ann Gastroenterol"},{"key":"R4-20240308","first-page":"52","article-title":"Development of non-alcoholic fatty liver disease (NAFLD) in young obese tribal subjects of Tripura: link between low 25(OH) vitamin-D levels and immune modulators","volume":"67","author":"Chakraborty","year":"2019","journal-title":"J Assoc Physicians India"},{"key":"R5-20240308","article-title":"Vitamin D-related immunomodulation in patients with liver cirrhosis","author":"Triantos","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R6-20240308","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","article-title":"Hepatic fibrosis: it is time to go with hepatic stellate cell-specific therapeutic targets","volume":"17","author":"Ezhilarasan","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R7-20240308","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20240308","doi-asserted-by":"crossref","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"R9-20240308","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"R10-20240308","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4166\/kjg.2015.66.6.320","article-title":"Inflammation and hepatic fibrosis, then hepatocellular carcinoma","volume":"66","author":"Kwon","year":"2015","journal-title":"Korean J Gastroenterol"},{"key":"R11-20240308","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091153","article-title":"Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence","volume":"10","author":"Cicero","year":"2018","journal-title":"Nutrients"},{"key":"R12-20240308","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.3748\/wjg.v20.i26.8341","article-title":"Modern approach to the clinical management of non-alcoholic fatty liver disease","volume":"20","author":"Del Ben","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R13-20240308","first-page":"V06150527","article-title":"Cirrhosis and liver fibrosis are potentially reversible","volume":"177","author":"Hansen","year":"2015","journal-title":"Ugeskr Laeger"},{"key":"R14-20240308","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3904\/kjim.2016.268","article-title":"Reversal of liver cirrhosis: current evidence and expectations","volume":"32","author":"Jung","year":"2017","journal-title":"Korean J Intern Med"},{"key":"R15-20240308","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1499-3872(14)60295-2","article-title":"New insight of vitamin D in chronic liver diseases","volume":"13","author":"Chen","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R16-20240308","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol Rev"},{"issue":"(suppl 1)","key":"R17-20240308","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s40279-017-0841-9","article-title":"Vitamin D and the athlete: current perspectives and new challenges","volume":"48","author":"Owens","year":"2018","journal-title":"Sports Med"},{"key":"R18-20240308","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4254\/wjh.v6.i12.901","article-title":"Vitamin D deficiency in chronic liver disease","volume":"6","author":"Iruzubieta","year":"2014","journal-title":"World J Hepatol"},{"key":"R19-20240308","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3760\/cma.j.issn.0366-6999.20131859","article-title":"Vitamin D receptor and its protective role in diabetic nephropathy","volume":"127","author":"Guan","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"R20-20240308","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1389557518666181025153712","article-title":"Association between vitamin D levels and nonalcoholic fatty liver disease: potential confounding variables","volume":"19","author":"Pacifico","year":"2019","journal-title":"Mini Rev Med Chem"},{"key":"R21-20240308","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.26390","article-title":"Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?","volume":"58","author":"Kwok","year":"2013","journal-title":"Hepatology"},{"key":"R22-20240308","doi-asserted-by":"crossref","DOI":"10.3390\/nu9090980","article-title":"1\u03b1,25-Dihydroxyvitamin D3 attenuates TGF-\u03b2-induced pro-fibrotic effects in human lung epithelial cells through inhibition of epithelial-mesenchymal transition","volume":"9","author":"Jiang","year":"2017","journal-title":"Nutrients"},{"key":"R23-20240308","doi-asserted-by":"crossref","first-page":"9276380","DOI":"10.1155\/2018\/9276380","article-title":"The biological activities of vitamin D and its receptor in relation to calcium and bone homeostasis, cancer, immune and cardiovascular systems, skin biology, and oral health","volume":"2018","author":"Khammissa","year":"2018","journal-title":"Biomed Res Int"},{"key":"R24-20240308","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cellimm.2012.10.002","article-title":"Protective role of the vitamin D receptor","volume":"279","author":"Yang","year":"2012","journal-title":"Cell Immunol"},{"key":"R25-20240308","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.biopha.2018.10.140","article-title":"Vitamin D and liver fibrosis: molecular mechanisms and clinical studies","volume":"109","author":"Udomsinprasert","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R26-20240308","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.2010.234666","article-title":"Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats","volume":"60","author":"Abramovitch","year":"2011","journal-title":"Gut"},{"key":"R27-20240308","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41374-019-0310-1","article-title":"Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl(4) mouse model","volume":"99","author":"Reiter","year":"2019","journal-title":"Lab Invest"},{"key":"R28-20240308","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s10620-019-05560-3","article-title":"Antifibrotic effects of 1,25(OH)(2)D(3) on nonalcoholic steatohepatitis in female mice","volume":"64","author":"Ma","year":"2019","journal-title":"Dig Dis Sci"},{"key":"R29-20240308","doi-asserted-by":"crossref","first-page":"105399","DOI":"10.1016\/j.jsbmb.2019.105399","article-title":"The deficiency and the supplementation of vitamin D and liver: lessons of chronic fructose-rich diet in mice","volume":"192","author":"Maia-Ceciliano","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R30-20240308","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4291\/wjgp.v10.i2.11","article-title":"Overview of studies of the vitamin D\/vitamin D receptor system in the development of non-alcoholic fatty liver disease","volume":"10","author":"Cimini","year":"2019","journal-title":"World J Gastrointest Pathophysiol"},{"key":"R31-20240308","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010077","article-title":"Beneficial effects of vitamin D treatment in an obese mouse model of non-alcoholic steatohepatitis","volume":"11","author":"Jahn","year":"2019","journal-title":"Nutrients"},{"key":"R32-20240308","doi-asserted-by":"crossref","first-page":"8742075","DOI":"10.1155\/2019\/8742075","article-title":"Evaluation of the effect derived from silybin with vitamin D and vitamin E administration on clinical, metabolic, endothelial dysfunction, oxidative stress parameters, and serological worsening markers in nonalcoholic fatty liver disease patients","volume":"2019","author":"Federico","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"R33-20240308","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R34-20240308","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R35-20240308","doi-asserted-by":"crossref","DOI":"10.3390\/nu10040496","article-title":"Vitamin D and the liver-correlation or cause?","volume":"10","author":"Keane","year":"2018","journal-title":"Nutrients"},{"key":"R36-20240308","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.25930","article-title":"Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus","volume":"56","author":"Barchetta","year":"2012","journal-title":"Hepatology"},{"issue":"(pt B)","key":"R37-20240308","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jsbmb.2016.08.004","article-title":"Physiological functions of Vitamin D in adipose tissue","volume":"165","author":"Abbas","year":"2017","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:10:31Z","timestamp":1709928631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020296"}},"subtitle":["A protocol for a systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":37,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020296","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}